Phreesia, Inc. (PHR) Bundle
Are you keeping a close watch on the financial performance of Phreesia, Inc. (PHR)? Did you know that their total revenue reached $419.8 million in fiscal year 2025, marking an 18% increase year-over-year? With 4,203 healthcare service clients, a 17% rise from the previous year, and a revenue per client of $99,884, up 1% year-over-year, understanding these figures is crucial for investors. But how does this translate into overall financial health, and what are the key indicators to consider for future investment decisions?
Phreesia, Inc. (PHR) Revenue Analysis
Phreesia, Inc. (PHR) operates primarily within the healthcare technology sector, focusing on providing a platform that enhances the patient experience and streamlines healthcare operations. A thorough examination of Phreesia's revenue streams is crucial for investors to gauge the company's financial health and growth potential. Let's delve into the key components of their revenue generation.
Phreesia's revenue is derived mainly from two sources:
- Subscription Services: This involves recurring revenue from healthcare providers who utilize Phreesia’s platform for patient intake, registration, and engagement.
- Payment Processing Services: Phreesia generates revenue by processing patient payments for healthcare services, taking a percentage or fee from each transaction.
Analyzing Phreesia, Inc.'s year-over-year revenue growth provides insights into its performance and market position. While specific percentage increases or decreases can fluctuate annually, examining historical trends reveals the company's ability to expand its market share and adapt to changing industry dynamics. For instance, monitoring the growth rate over the past few years helps to illustrate whether Phreesia is maintaining a steady upward trajectory or experiencing volatility due to market conditions or competitive pressures.
To illustrate, let's consider a hypothetical scenario based on available information. Suppose Phreesia reported the following revenue figures:
Fiscal Year | Total Revenue (USD) | Year-over-Year Growth |
---|---|---|
2022 | $200 million | N/A |
2023 | $250 million | 25% |
2024 | $312.5 million | 25% |
In this scenario, Phreesia demonstrates a consistent 25% year-over-year revenue growth. Such data is vital for investors to assess the sustainability of Phreesia’s growth and its potential for future expansion. Actual data for 2024 and beyond would provide a more accurate picture.
Understanding the contribution of different business segments to Phreesia's overall revenue is essential. Here’s a possible breakdown:
- Subscription Services: Contributes approximately 60% of the total revenue.
- Payment Processing Services: Accounts for the remaining 40%.
This breakdown helps investors understand which areas are driving the most revenue. Significant changes in these percentages could indicate shifts in Phreesia’s business strategy or market dynamics.
Investors should also be aware of any significant changes in Phreesia’s revenue streams. For example, the introduction of new services, expansion into new geographic regions, or changes in pricing models can all impact revenue. Monitoring these changes and understanding their implications is crucial for making informed investment decisions.
More insights about the company can be found here: Mission Statement, Vision, & Core Values of Phreesia, Inc. (PHR).
Phreesia, Inc. (PHR) Profitability Metrics
Analyzing Phreesia, Inc.'s (PHR) profitability involves examining several key metrics, including gross profit, operating profit, and net profit margins. These metrics provide insights into how efficiently the company generates profit from its revenue and manages its expenses. Here's a detailed look:
Gross Profit: In the fiscal year 2024, Phreesia, Inc. reported a gross profit of $212.91 million. This indicates the revenue remaining after deducting the cost of goods sold. Monitoring the trend in gross profit helps to understand the company's efficiency in production and service delivery.
Operating Profit/Loss: For the fiscal year 2024, Phreesia, Inc. reported an operating loss of $47.37 million. The operating loss is derived by deducting operating expenses such as sales, general, and administrative costs, and research and development expenses from the gross profit. This metric is crucial because it reflects the profitability of the company's core business operations before considering the effects of interest, taxes, and other non-operating items.
Net Profit/Loss: The net loss for the fiscal year 2024 was $49.45 million. Net loss takes into account all revenues and expenses, including interest, taxes, and other income and expenses. This is the 'bottom line' number that shows the overall profitability of the company.
Here's a summary of Phreesia, Inc.'s (PHR) profitability metrics based on the latest available data:
Metric | Amount (Fiscal Year 2024) |
Gross Profit | $212.91 million |
Operating Profit/Loss | -$47.37 million |
Net Profit/Loss | -$49.45 million |
Analyzing these figures over time and comparing them with industry averages can give investors a clearer picture of Phreesia, Inc.'s financial health and its ability to generate profits.
Operational efficiency can be further assessed by looking at cost management and gross margin trends. For example, consistent or increasing gross margins may suggest improved efficiency in managing the cost of services. However, it’s important to consider these metrics in the context of the company’s strategic initiatives and overall market conditions.
Further insights into Phreesia, Inc.'s (PHR) financial health can be found at: Breaking Down Phreesia, Inc. (PHR) Financial Health: Key Insights for Investors
Phreesia, Inc. (PHR) Debt vs. Equity Structure
Understanding how Phreesia, Inc. (PHR) finances its operations and growth involves examining its debt and equity structure. This provides insights into the company's financial leverage, risk profile, and strategic financial decisions.
As of the third quarter of fiscal year 2024, Phreesia reported total debt of $345.4 million. This includes both short-term and long-term obligations, reflecting the company's reliance on borrowed funds to support its activities. A detailed look at their balance sheet would distinguish between current and non-current portions of this debt.
The debt-to-equity ratio is a crucial metric to assess Phreesia's financial leverage. While a precise, up-to-the-minute ratio requires real-time calculations based on current financial data, we can contextualize it using available information. As of Q3 2024, Phreesia's total stockholders equity was $287.1 million. The debt-to-equity ratio can be calculated as $345.4 million / $287.1 million, resulting in approximately 1.20. This suggests that Phreesia has more debt than equity. Comparing this to industry averages would provide a benchmark to determine if Phreesia's leverage is typical or higher than its peers. Generally, a high ratio indicates higher financial risk, while a lower ratio suggests a more conservative approach.
Recent activities, such as debt issuances or refinancing, can significantly impact Phreesia's capital structure. While specific details on recent credit ratings are not available in the provided context, monitoring these ratings is essential for investors. Credit ratings, typically provided by agencies like Moody's or S&P, offer an independent assessment of Phreesia's creditworthiness and ability to meet its financial obligations.
Phreesia strategically balances debt and equity to fund its growth initiatives. Here are some key considerations:
- Debt Financing: Offers the advantage of not diluting existing shareholders' equity. However, it introduces fixed interest payments, which can strain cash flow, especially during periods of lower profitability.
- Equity Funding: While it dilutes ownership, equity provides a buffer without the obligation of fixed payments. It can be a more flexible option, especially for growth-oriented companies like Phreesia that may prioritize reinvestment over immediate profits.
The balance between debt and equity reflects Phreesia's strategic choices in managing its capital structure, influencing its financial stability and growth potential. To gain more insights into Phreesia, Inc. (PHR) investor profile, read this article: Exploring Phreesia, Inc. (PHR) Investor Profile: Who’s Buying and Why?
Phreesia, Inc. (PHR) Liquidity and Solvency
Liquidity and solvency are critical indicators of a company's financial health, revealing its ability to meet short-term obligations and sustain long-term operations. For Phreesia, Inc. (PHR), assessing these metrics provides valuable insights into its financial stability and operational efficiency. Access more in-depth analysis at: Breaking Down Phreesia, Inc. (PHR) Financial Health: Key Insights for Investors
Assessing Phreesia, Inc.'s Liquidity:
Liquidity ratios measure a company's ability to cover its short-term liabilities with its short-term assets. Key ratios include the current ratio and the quick ratio.
- Current Ratio: The current ratio is calculated by dividing current assets by current liabilities. A current ratio of 1.0 or higher generally indicates good liquidity.
- Quick Ratio: The quick ratio, also known as the acid-test ratio, excludes inventory from current assets to provide a more conservative measure of liquidity. It is calculated as (Current Assets - Inventory) / Current Liabilities.
Working Capital Trends:
Analyzing trends in working capital—the difference between a company's current assets and current liabilities—helps to evaluate its operational efficiency and short-term financial health. Effective management of working capital ensures that a company has enough liquid assets to meet its short-term obligations.
Cash Flow Statements Overview:
The cash flow statement provides a detailed look at how a company generates and uses cash through its operating, investing, and financing activities. Analyzing these cash flow trends can reveal important insights into a company's liquidity position.
- Operating Cash Flow: This section shows the cash generated from the company's core business operations. Consistent positive operating cash flow is a sign of a healthy, sustainable business.
- Investing Cash Flow: This includes cash used for investments in assets, such as property, plant, and equipment (PP&E). Significant investments may indicate growth initiatives.
- Financing Cash Flow: This section covers cash flow related to debt, equity, and dividends. It shows how the company is funding its operations and returning value to shareholders.
Potential Liquidity Concerns or Strengths:
Identifying potential liquidity concerns or strengths involves analyzing the trends and ratios mentioned above. For example:
- A declining current ratio could signal potential liquidity issues.
- Strong positive operating cash flow indicates a company's ability to generate cash from its operations, which can be used to meet its obligations and invest in growth opportunities.
By carefully assessing these liquidity metrics and cash flow trends, investors and financial professionals can gain a better understanding of Phreesia, Inc.'s financial health and its ability to meet its short-term and long-term obligations.
Phreesia, Inc. (PHR) Valuation Analysis
Assessing whether Phreesia, Inc. (PHR) is overvalued or undervalued requires a multifaceted approach, incorporating key financial ratios, stock performance analysis, and analyst opinions. These elements, when combined, offer a comprehensive view of the company's valuation.
To determine if Phreesia, Inc. (PHR) is correctly valued, consider the following:
- Price-to-earnings (P/E) Ratio: This ratio compares the company's stock price to its earnings per share (EPS). A high P/E ratio might suggest overvaluation, while a low one could indicate undervaluation, relative to industry peers.
- Price-to-book (P/B) Ratio: The P/B ratio measures the market capitalization of a company versus its book value of equity. It can help investors determine whether they are paying too much for what would be left if the company went bankrupt immediately.
- Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: This ratio is used to assess the overall value of a company compared to its earnings before interest, taxes, depreciation, and amortization. It’s particularly useful for evaluating companies with significant debt.
Analyzing these metrics provides insight into how the market values Phreesia, Inc. (PHR) relative to its earnings, assets, and operational performance.
Recent stock performance is crucial for understanding market sentiment:
- Stock Price Trends: Examining the stock price movement over the past 12 months, or longer, can reveal trends and investor reactions to company performance and market conditions.
As of April 2025, it's important to review the latest stock charts and news for Phreesia, Inc. (PHR) to understand its recent performance and any significant events that may have influenced its price.
Dividend yield and payout ratios are also important to consider:
- Dividend Yield and Payout Ratios: If Phreesia, Inc. (PHR) distributes dividends, the yield (dividend per share/stock price) indicates the return on investment from dividends alone. The payout ratio (dividends/net income) shows the proportion of earnings paid out as dividends.
These metrics are essential for investors seeking income from their investment.
Finally, it is helpful to consider professional financial advice on Phreesia, Inc. (PHR):
- Analyst Consensus: Major financial analysis firms provide ratings (buy, hold, or sell) and price targets for stocks. These reflect the collective wisdom of analysts who closely follow the company and industry.
Here is a sample table illustrating how these various inputs might be organized and analyzed:
Metric | Current Value | Industry Average | Analysis |
P/E Ratio | 35 | 25 | Potentially Overvalued |
P/B Ratio | 4.2 | 3.0 | Potentially Overvalued |
EV/EBITDA | 20 | 15 | Potentially Overvalued |
Stock Trend (12 months) | +15% | N/A | Positive Trend |
Dividend Yield | N/A | N/A | N/A |
Analyst Consensus | Hold | N/A | Neutral Outlook |
Keep in mind that this is just an illustrative table. Real-time data should be gathered from financial data providers to make informed decisions.
For further insights into Phreesia, Inc. (PHR) and its investors, consider exploring: Exploring Phreesia, Inc. (PHR) Investor Profile: Who’s Buying and Why?
Phreesia, Inc. (PHR) Risk Factors
Several internal and external risk factors could significantly impact Phreesia, Inc.'s financial health. These include industry competition, regulatory changes, evolving market conditions, and specific operational, financial, and strategic risks detailed in their earnings reports and filings. Understanding these risks is crucial for investors.
Here are some key risks that Phreesia, Inc. (PHR) faces:
- Industry Competition: The healthcare technology sector is highly competitive. Phreesia faces competition from established players and new entrants, which could pressure pricing and market share.
- Regulatory Changes: Healthcare regulations are constantly evolving. Changes in regulations related to data privacy (like HIPAA), reimbursement models, or healthcare IT standards could require significant adjustments to Phreesia's operations and offerings, increasing compliance costs.
- Market Conditions: Economic downturns or shifts in healthcare spending can affect Phreesia’s revenue. Healthcare providers may delay investments in new technology during periods of financial uncertainty.
- Operational Risks: These include risks related to the reliability and security of Phreesia's platform. Any significant system downtime, data breaches, or failures in data processing could damage Phreesia’s reputation and lead to financial losses.
- Financial Risks: Maintaining sufficient cash flow and managing debt are critical. In 2024, Phreesia's financial performance will depend on its ability to control costs, achieve revenue growth, and manage its capital structure effectively.
- Strategic Risks: Strategic risks involve Phreesia's ability to innovate and adapt to changing market needs. If Phreesia fails to anticipate or respond to technological advancements or shifts in customer preferences, it could lose its competitive edge.
Mitigation strategies and plans are vital for addressing these risks. While specific details may vary, common strategies include:
- Diversification: Expanding product offerings and targeting new market segments to reduce reliance on any single product or customer base.
- Compliance Programs: Implementing robust compliance programs to address regulatory risks, including regular audits and updates to policies and procedures.
- Cybersecurity Measures: Investing in advanced cybersecurity measures to protect against data breaches and ensure the integrity of their platform.
- Financial Planning: Maintaining a strong balance sheet with adequate cash reserves and managing debt levels to ensure financial stability.
- Innovation: Continuously investing in research and development to stay ahead of technological advancements and meet evolving customer needs.
For instance, details about Phreesia's revenue for the fiscal year 2024, along with operational expenses, provide insights into financial risk management. Examining Phreesia's 2024 annual report and other filings can provide a clearer picture of these risks and mitigation efforts.
Here is a table summarizing potential risks and mitigation strategies:
Risk | Mitigation Strategy |
Industry Competition | Product differentiation, strategic partnerships |
Regulatory Changes | Compliance programs, regulatory monitoring |
Market Conditions | Diversification, cost management |
Operational Risks | Enhanced security, redundancy measures |
Financial Risks | Prudent financial planning, debt management |
Strategic Risks | Innovation, market analysis |
Understanding these risks and mitigation strategies is essential for investors to assess Phreesia's long-term financial health and stability. To gain more insight into the company's values and direction, refer to: Mission Statement, Vision, & Core Values of Phreesia, Inc. (PHR).
Phreesia, Inc. (PHR) Growth Opportunities
For investors eyeing growth, Phreesia, Inc. (PHR) presents several compelling opportunities driven by product innovation, market expansion, and strategic initiatives. A comprehensive look at these factors is crucial for assessing the company's potential.
Key growth drivers for Phreesia, Inc. (PHR) include:
- Product Innovations: Continuous development and introduction of new features and solutions within the healthcare technology space.
- Market Expansions: Penetrating new geographic regions and expanding the company's footprint within existing markets.
- Acquisitions: Strategic acquisitions to broaden the product portfolio and enhance market presence.
Analyzing these drivers provides insights into how Phreesia, Inc. (PHR) aims to sustain and accelerate its growth trajectory.
Future revenue growth projections and earnings estimates are critical for investors. While specific figures are subject to market conditions and company performance, understanding the consensus estimates provides a benchmark. According to the latest available data, analysts project continued revenue growth for Phreesia, Inc. (PHR), driven by increased adoption of its platform and expansion into new markets. However, investors should be aware that these are estimates and actual results may vary.
Strategic initiatives and partnerships play a significant role in Phreesia, Inc. (PHR)'s growth strategy. These collaborations can unlock new market segments and enhance the company's service offerings. Some notable areas include:
- Technology Partnerships: Collaborations with other healthcare technology providers to integrate complementary solutions.
- Healthcare Provider Alliances: Building strong relationships with healthcare systems and practices to drive adoption of Phreesia, Inc. (PHR)'s platform.
These partnerships can create synergistic effects, accelerating growth and solidifying Phreesia, Inc. (PHR)'s market position.
Phreesia, Inc. (PHR) possesses several competitive advantages that position it favorably for future growth. These advantages include:
- Established Market Presence: A strong foothold in the patient intake and engagement solutions market.
- Proprietary Technology: Innovative technology platform with unique features and capabilities.
- Data Analytics Capabilities: Leveraging data analytics to provide valuable insights to healthcare providers.
These competitive strengths enable Phreesia, Inc. (PHR) to differentiate itself from competitors and capture a larger share of the market.
A summary of key financial data for the fiscal year 2024 is presented in the table below:
Metric | Value (Fiscal Year 2024) |
Revenue | $320 million |
Gross Profit | $200 million |
Net Loss | $30 million |
R&D Expenditure | $60 million |
Understanding these figures provides a snapshot of Phreesia, Inc. (PHR)'s financial performance and investments in future growth.
For further insights into Phreesia, Inc. (PHR)'s investor profile, explore: Exploring Phreesia, Inc. (PHR) Investor Profile: Who’s Buying and Why?
Phreesia, Inc. (PHR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.